Amylyx Pharmaceuticals

About:

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Top Investors: Perceptive Advisors, Bain Capital Life Sciences, Lysosomal Therapeutics, Viking Global Investors, Alpha Wave Global

Description:

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration.

Total Funding Amount:

$448M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2014-01-01

Founders:

Joshua Cohen, Justin Klee

Number of Employees:

251-500

Last Funding Date:

2022-10-06

IPO Status:

Public

Industries: